Tag: famous cases of research misconduct

  • Recent History of Research Misconduct Scrutiny

    The recent history of attention to research misconduct runs from the 1986 Baltimore Case — which forced the creation of the US Office of Research Integrity (ORI) — through the 2000s rise of paper mills and image manipulation, to today’s concern that generative AI can fabricate entire papers, datasets, and images at a scale no journal can screen manually. Each phase added new oversight infrastructure without resolving the underlying incentive to publish at any cost.

    Research misconduct is defined by US federal policy as fabrication, falsification, or plagiarism (FFP) in proposing, performing, or reviewing research, or in reporting research results. This article traces how public and institutional attention to that problem has shifted — from a single congressional hearing in 1981 to a global infrastructure of retraction databases, publication-ethics bodies, and AI-detection tooling.

    The Baltimore Case: the event that built America’s oversight system

    The single most consequential episode in this history began in 1986, when postdoctoral researcher Margot O’Toole challenged the validity of data in an immunology paper published in Cell, co-authored by Nobel laureate David Baltimore and led by Thereza Imanishi-Kari. What started as a laboratory dispute became a decade-long federal investigation involving the NIH, congressional hearings chaired by Representative John Dingell, and forensic analysis of lab notebooks by the US Secret Service.

    Baltimore was never accused of fraud, but his public defence of Imanishi-Kari drew sustained criticism and cost him the presidency of Rockefeller University in 1991. Imanishi-Kari was formally cleared in 1996, when an appeals panel found her records sloppy but the evidence of intentional fabrication insufficient. By then the case had already reshaped US science policy.

    Congressional attention actually predates the Baltimore Case: Representative Albert Gore Jr held the first hearing on research misconduct in 1981, after roughly twelve cases surfaced at major US research centres between 1974 and 1981. It was the Baltimore Case’s decade of scrutiny, though, that cemented the need for a permanent federal body rather than ad hoc congressional inquiries.

    From ORI to COPE: institutionalising oversight (1992-2005)

    The US Office of Research Integrity (ORI) was formally established within the Department of Health and Human Services in May 1992, consolidating two predecessor offices created in 1989. The NIH Revitalization Act of 1993 made ORI independent and replaced “scientific misconduct” with “research misconduct” in federal policy, widening the definition beyond laboratory science.

    The Federal Research Misconduct Policy, published in the Federal Register on 6 December 2000, gave the US its first government-wide fabrication/falsification/plagiarism definition, still the reference ORI applies today. Internationally, the UK created the UK Research Integrity Office (UKRIO) in 2006, and the Committee on Publication Ethics (COPE) was founded by medical journal editors in 1997, giving publishers — not just funders — a formal adjudication mechanism.

    This period set the template still in use: institutions investigate first, an oversight body reviews the finding, and journals retract independently of any funder decision.

    Paper mills and image manipulation: the digital-era escalation

    Digital publishing made two categories of misconduct systemically visible. First, image manipulation: a 2016 screening study by microbiologist Elisabeth Bik and colleagues in mBio examined 20,621 papers across 40 journals and found 3.8% contained inappropriate image duplication, roughly half apparently deliberate. The 2005-2006 exposure of South Korean stem-cell researcher Woo Suk Hwang’s fabricated cloning results, which relied partly on manipulated photographs, pushed journals toward routine image screening for the first time.

    Second, paper mills: for-profit operations that manufacture fraudulent manuscripts, often with fabricated data or templated “tortured phrase” plagiarism, sold to researchers under career pressure to publish. Documented paper-mill output dates to the 2000s but accelerated sharply through the 2010s.

    The consequence is visible in the retraction record. 2023 was, per Nature’s coverage of Crossref and Retraction Watch data, a record year with over 10,000 retractions globally, a large share traced to paper-mill activity at a small number of publishers, notably Hindawi. That same year the Retraction Watch Database — previously subscription-only — was made freely available after Crossref took over its stewardship.

    Milestones in the recent history of attention to research misconduct
    Year Event Significance
    1981 First congressional hearing (Rep. Albert Gore Jr) Research misconduct becomes a public policy issue in the US
    1986-1996 Baltimore Case investigation and appeal Exposes inadequacy of ad hoc federal response; drives creation of ORI
    1992 Office of Research Integrity (ORI) established First permanent federal body dedicated to research misconduct
    1997 Committee on Publication Ethics (COPE) founded Gives journals a shared ethics framework independent of funders
    2000 Federal Research Misconduct Policy published Standardises the fabrication/falsification/plagiarism (FFP) definition
    2005-2006 Hwang Woo-suk stem-cell fraud exposed Establishes routine image-manipulation screening at journals
    2010s Paper mills scale up Fabricated manuscripts and fake peer review sold commercially
    2023 Record 10,000+ retractions; Retraction Watch Database opened via Crossref Retraction data becomes a shared, searchable public resource
    2023-present Generative AI text and image fabrication concerns Detection tools race to keep pace with synthetic fabrication at scale

    AI-era fabrication: what has genuinely changed

    Generative AI has not created a new category of misconduct — fabrication, falsification, and plagiarism remain the operative definitions — but it changes the economics of producing it. Large language models draft plausible manuscript text at near-zero marginal cost, and image generators can produce synthetic western blots or microscopy images that mimic genuine experimental output. Paper mills, already operating at scale before 2023, are widely reported to be early adopters of these tools.

    What is different is detection asymmetry: AI-generated text is often hard to distinguish from human writing using plagiarism tools built to match against a corpus of prior text, not to catch novel synthetic prose. Journals are responding with statistical-anomaly detection and image-forensics tooling, but this is explicitly reactive — the same pattern seen after the Baltimore Case and the Hwang case, where scrutiny follows scandal rather than anticipating it. The publish-or-perish incentive that produced the Baltimore Case in 1986 is the same incentive AI-assisted fabrication now threatens to industrialise further.

    Common questions on the history of research misconduct

    What are some examples of research misconduct?

    Under the US Federal Research Misconduct Policy, examples fall into three categories: fabrication (inventing data or results), falsification (manipulating research materials, equipment, or processes, or altering/omitting data), and plagiarism (appropriating another’s ideas, processes, results, or words without credit). Honest error and differences of scientific opinion are explicitly excluded.

    What group formed in 1992 to investigate scientific misconduct?

    The Office of Research Integrity (ORI) was established in May 1992 within the US Department of Health and Human Services, consolidating two predecessor offices — the Office of Scientific Integrity and the Office of Scientific Integrity Review — created in 1989. ORI remains the federal oversight body for misconduct in Public Health Service-funded research.

    What are the effects of research misconduct in today’s society?

    Research misconduct erodes trust between researchers, institutions, and funders, and it can distort the evidence base that clinical guidelines, policy decisions, and further research rely on. High-profile cases also fuel broader public scepticism about science, which institutions such as COPE and ORI argue makes rigorous, transparent investigation processes essential rather than optional.

    Implications for institutions, publishers, and funders

    For research administrators, the pattern is instructive: every major expansion of oversight infrastructure — ORI in 1992, COPE in 1997, routine image screening after 2006, the open Retraction Watch Database in 2023 — followed a scandal rather than preceding one. Institutions waiting for their own “Baltimore Case” before investing in integrity training and screening tools are, by this history, already behind.

    • Establish clear, documented processes for handling allegations before one arises, mirroring the institutional-first-response model ORI has required since 1989.
    • Adopt image-integrity and plagiarism screening as a routine pre-submission and pre-award step, not a post-publication response.
    • Track Retraction Watch Database entries relevant to your institution’s output as a standing due-diligence practice, now that the database is freely accessible via Crossref.
    • Treat AI-generated text and image detection as an evolving capability requiring periodic reassessment, not a one-off procurement decision.

    The throughline from 1986 to today is not that misconduct has become more common, but that the tools for producing it — and, gradually, for detecting it — have industrialised in step with the technology available in each era. The next inflection point in this history will likely be defined by whether detection capability can keep pace with generative AI, or whether institutional attention once again waits for the next public scandal to force the issue.

  • Stanford President Research Misconduct Timeline

    Marc Tessier-Lavigne resigned as Stanford University president on 19 July 2023, days after a Special Committee-commissioned scientific panel completed a seven-month review of 12 papers he had co-authored. The panel found repeated data manipulation in laboratories he ran but cleared him of personally falsifying data. His stanford president research misconduct case remains one of the clearest recent examples of a university running a named, transparent misconduct review to its conclusion.

    Research misconduct, as defined by the US Office of Research Integrity, is “fabrication, falsification, or plagiarism in proposing, performing, or reviewing research, or in reporting research results.” Stanford’s inquiry into its own president tested that definition against a public figure, under public scrutiny, in real time — which is what makes its process, rather than its verdict alone, instructive for research administrators.

    What Triggered the Stanford Research Misconduct Investigation?

    The trigger was student journalism, not an internal audit. On 29 November 2022, The Stanford Daily, reported by then-freshman Theo Baker, published allegations that several papers co-authored by Tessier-Lavigne contained manipulated images, drawing on critiques that had circulated anonymously on the post-publication review site PubPeer since 2015.

    The same week, The EMBO Journal confirmed it had separately opened its own inquiry into a 2008 paper Tessier-Lavigne co-authored — a detail largely absent from mainstream coverage of the case, and a reminder that journal-level scrutiny and institutional review are distinct, parallel tracks that do not wait on each other.

    How Did Stanford’s Special Committee Investigate the Allegations?

    Stanford’s Board of Trustees announced in December 2022 that a Special Committee would review the claims. It appointed Mark Filip, a former federal judge and partner at Kirkland & Ellis, to lead the fact-finding, supported by a five-member scientific panel: Hollis Cline (Scripps Research), Kafui Dzirasa (Duke University), Steven Hyman (Harvard University, provost emeritus), Randy Schekman (UC Berkeley, former editor-in-chief of PNAS), and Shirley Tilghman (Princeton University, former president).

    Between roughly January and June 2023, the panel examined 12 papers, interviewed lab members and co-authors, and reviewed underlying research data rather than relying on published figures alone — a distinction that matters because most disputed images had already passed peer review once.

    Date Event
    2015 onward Anonymous image-manipulation critiques accumulate on PubPeer
    29 Nov 2022 Stanford Daily publishes first report; EMBO Journal opens a parallel inquiry
    Dec 2022 Board of Trustees announces a Special Committee review
    Jan–Jun 2023 Mark Filip and a five-member scientific panel investigate 12 papers
    17 Jul 2023 Panel delivers 95-page final report to the Board
    19 Jul 2023 Tessier-Lavigne announces resignation, effective 31 Aug 2023
    31 Aug 2023 Resignation takes effect; Richard Saller becomes interim president
    4 Apr 2024 Jonathan Levin named Stanford’s 13th president
    1 Aug 2024 Levin assumes office

    What Did the Scientific Panel’s Report Conclude?

    The panel’s 95-page report, released on 17 July 2023, concluded that laboratories Tessier-Lavigne ran had engaged in “manipulation of research data” across several papers, and that he was principal author on five of the 12 papers reviewed. It found no evidence he personally fabricated or falsified data, but concluded he had not taken sufficiently decisive steps to correct the scientific record once problems were flagged.

    Following the report, Tessier-Lavigne said he intended to retract at least three papers and correct two more, all originally published between 1999 and 2009 — before his Stanford presidency began. Two papers were formally retracted from Science on 31 August 2023, according to Retraction Watch.

    • 12 co-authored papers examined by the scientific panel
    • 5 papers on which Tessier-Lavigne was principal author
    • At least 3 papers slated for retraction, 2 for correction
    • 1999–2009: publication window for the papers in question

    The Resignation Timeline: From Report to Successor

    Tessier-Lavigne announced his resignation on 19 July 2023, two days after receiving the panel’s findings, saying Stanford needed a president “whose leadership is not hampered by such discussions.” The resignation took effect on 31 August 2023, ending a seven-year presidency.

    Richard Saller, a classicist and former Stanford provost, served as interim president from September 2023. Stanford’s trustees named Jonathan Levin, dean of the Graduate School of Business, as the university’s 13th president on 4 April 2024; Levin assumed office on 1 August 2024 — just over a year after the resignation was announced.

    Answer-First Q&A on the Tessier-Lavigne Case

    When did Marc Tessier-Lavigne resign as Stanford president?

    Marc Tessier-Lavigne announced his resignation on 19 July 2023, two days after Stanford’s Special Committee released its scientific panel’s final report. His resignation took effect on 31 August 2023, and Richard Saller became interim president the same day.

    What did Stanford’s investigation find about the research?

    The scientific panel found that laboratories Tessier-Lavigne led had engaged in repeated data manipulation across several papers examined, out of 12 reviewed in total. It attributed the manipulation to others in the labs, not to Tessier-Lavigne personally, but faulted his oversight and slow correction of the record.

    Was Tessier-Lavigne found to have committed research misconduct himself?

    No. The panel cleared Tessier-Lavigne of personally fabricating or falsifying data. It concluded he was unaware of the manipulation at the time of publication but should have acted more decisively once concerns were raised, particularly regarding papers on which he was principal author.

    What counts as research misconduct under research-integrity standards?

    Research misconduct is generally defined as fabrication, falsification, or plagiarism in proposing, performing, or reporting research — the definition used by the US Office of Research Integrity. Authorship disputes, honest error, and differences of scientific judgement are explicitly excluded from this definition.

    Implications for Institutional Research-Integrity Response

    The Tessier-Lavigne case is a rare instance where a governing board investigated its own chief executive using outside legal counsel and a named, independent scientific panel, then published the resulting report in full. That combination — external fact-finders, disclosed panel membership, and a public report — is closer to the process integrity that bodies such as the Committee on Publication Ethics (COPE) recommend for misconduct investigations than the closed-door reviews typical of many institutions.

    For research administrators, the case demonstrates that reputational and governance consequences can follow from oversight failures even where personal fabrication is not established. It also shows that journal-level inquiries (EMBO Journal) and institutional inquiries can run in parallel without either resolving the other, meaning research administration teams should track both tracks rather than treating a clean institutional finding as the final word. A decade-old PubPeer thread, in this case, outlasted the papers’ authors’ careers before triggering formal review — underscoring why routine, proactive image-integrity screening matters more than reactive response once allegations become public.

  • Francesca Gino Research Misconduct Case Study

    The Francesca Gino research misconduct case is the 2021–2025 dispute in which Harvard Business School investigated, and ultimately dismissed, a tenured professor after concluding she had fabricated data in four published studies — a process that also produced a $25 million lawsuit, a Harvard countersuit, and one of the rare tenure revocations in the university’s modern history.

    Research misconduct, in the definition used by US federal policy and echoed by bodies such as the Committee on Publication Ethics (COPE), is the fabrication, falsification, or plagiarism of data in proposing, performing, or reviewing research. The Gino case is unusual not for the underlying allegation but for how visible the institutional machinery became: an 18-month internal inquiry, a 1,200-page report, a public unsealing order, and two overlapping lawsuits that together offer a rare, document-level view of how one major research university actually runs a misconduct investigation.

    What is the Francesca Gino research misconduct case?

    Francesca Gino was the Tandon Family Professor of Business Administration at Harvard Business School, where her research on honesty and ethical behaviour made her one of the most cited figures in behavioural science. Concerns about her data first surfaced around 2020, when a doctoral student’s replication attempt failed to reproduce a widely publicised Gino networking study. That failure led to a wider audit that eventually implicated four separate papers.

    Harvard’s internal investigation committee — three senior Harvard Business School faculty, assisted by an outside forensic firm — concluded that Gino had committed research misconduct intentionally, knowingly, or recklessly. The university placed her on unpaid administrative leave in June 2023 and, in May 2025, revoked her tenure and ended her employment before her two-year suspension had even run its course.

    How did Harvard’s misconduct investigation unfold?

    The Gino case shows a misconduct investigation moving through distinct, document-traceable stages rather than a single disciplinary event. Each stage generated its own record, several of which later became public through litigation.

    • 2020–2021: Doctoral candidate Zoé Ziani fails to replicate a Gino personal-networking study and raises concerns internally.
    • Autumn 2021: The Data Colada team — Uri Simonsohn, Leif Nelson, and Joseph Simmons — contacts Harvard Business School about anomalies in four Gino papers.
    • 2021–2023: Harvard conducts an internal investigation described by the HBS dean as an “18-month” process, producing a 1,200-page report under Case RI21-001.
    • June 2023: HBS places Gino on unpaid administrative leave; Data Colada simultaneously publishes its “Data Falsificada” blog series detailing the alleged anomalies.
    • August 2023: Gino files a $25 million lawsuit against Harvard, HBS Dean Srikant Datar, and the three Data Colada researchers, alleging defamation and gender discrimination.
    • March 2024: Judge Myong J. Joun orders the unsealing, with redactions, of Harvard’s 1,200-page investigation report.
    • September 2024: The court dismisses Gino’s defamation and privacy claims against both Harvard and the Data Colada defendants in full; breach-of-contract and gender-discrimination claims are allowed to proceed.
    • May 2025: The Harvard Corporation revokes Gino’s tenure and terminates her employment.
    • September 2025: Harvard sues Gino for defamation, alleging she submitted a falsified dataset to the university during the dispute.

    Notably, under US federal research-integrity rules, the Office of Research Integrity (ORI) only has jurisdiction over misconduct in Public Health Service-funded research. Much of Gino’s behavioural-science work fell outside that remit, meaning the entire investigation design — committee composition, evidentiary standard, and appeal rights — was governed solely by Harvard’s own internal policy rather than a codified federal or funder-mandated process.

    What evidence did investigators find in the retracted papers?

    Four papers sit at the centre of the case. All four have since been retracted, though the first was flagged for an unrelated data issue before the wider investigation began.

    Paper Journal Year published Retraction status
    “Signing at the beginning makes ethics salient…” (Shu, Mazar, Gino, Ariely, Bazerman) Proceedings of the National Academy of Sciences 2012 Retracted September 2021
    “Evil Genius? How Dishonesty Can Lead to Greater Creativity” (Gino, Wiltermuth) Psychological Science 2014 Retracted 2023
    “The Moral Virtue of Authenticity…” (Gino, Kouchaki, Galinsky) Psychological Science 2015 Retracted 2023
    “Why Connect? Moral Consequences of Networking…” (Gino, Kouchaki, Casciaro) Journal of Personality and Social Psychology 2020 Retracted 2023

    According to Harvard’s unsealed report, Gino offered investigators two explanations for the data irregularities: honest error by her or her research assistants, or tampering by a malicious third party with access to her files. The committee found neither explanation plausible, writing that her “repeated and strenuous argument” for a bad-actor scenario across four separate studies undermined the credibility of her broader testimony.

    A separate, self-organised accountability effort — the Many Co-Authors Project — later reviewed 56 papers naming Gino as involved in data collection. Its contributors reported that for roughly 60% of those papers, responding co-authors said they had never had access to the underlying raw data, a data-provenance gap that goes beyond the four papers formally retracted.

    What happened in the Gino v. Harvard litigation?

    Litigation is what made this a document-level case study rather than a private disciplinary matter. Gino’s August 2023 suit sought $25 million and alleged defamation, gender discrimination under Title IX, and breach of contract. Harvard’s decision to submit its full 1,200-page report as court evidence — and a subsequent judicial order to unseal it — meant the investigative record itself became a matter of public record, rather than remaining confidential under standard university misconduct procedure.

    Did Harvard sue Francesca Gino for defamation?

    Yes. In September 2025, Harvard filed its own defamation suit against Gino, alleging she submitted a falsified dataset to the university in an attempt to prove she had not committed data fraud. This followed her original 2023 defamation claim against Harvard, which a federal judge dismissed in September 2024.

    Does Francesca Gino still work at Harvard?

    No. The Harvard Corporation, the university’s top governing board, revoked Gino’s tenure and terminated her employment in May 2025, ending her unpaid suspension before it was due to expire. Harvard described tenure revocation as an extremely rare step not used at the institution for decades.

    Did Harvard revoke Francesca Gino’s tenure over falsifying data allegations?

    Yes. Harvard’s investigation committee, made up of three senior HBS faculty, concluded after an 18-month inquiry that Gino had committed research misconduct “intentionally, knowingly, or recklessly,” a finding that directly preceded the termination proceedings completed in 2025.

    What does the case reveal about institutional misconduct processes?

    For research administrators, the Gino case is less a story about one professor than a stress test of how an elite institution structures a misconduct inquiry when there is no external regulator compelling a specific procedure. Several implications stand out.

    • Investigation length is a real institutional risk. An 18-month internal inquiry, followed by two further years of litigation before a final personnel decision, shows how misconduct cases without a codified stage-gate process (unlike, for example, COPE’s published flowcharts) can extend for years and generate parallel legal exposure.
    • Confidentiality and public interest can collide. Harvard initially treated its 1,200-page report as confidential; a court order — not university policy — forced its unsealing. Institutions relying purely on internal confidentiality norms should anticipate that litigation can override them.
    • Peer self-auditing is emerging as a parallel accountability layer. The Many Co-Authors Project shows co-authors organising their own data-provenance review independently of the university process, filling a gap that formal institutional investigation did not cover at scale.
    • Whistleblower exposure has financial consequences. Data Colada’s team faced personal litigation risk for reporting anomalies, prompting outside researchers to crowdfund legal costs — a chilling-effect dynamic that institutional research-integrity policy rarely addresses directly.

    Frameworks such as the UK’s Concordat to Support Research Integrity and COPE’s core practices exist precisely to standardise the stages this case worked through ad hoc: initial concern, preliminary assessment, formal investigation, evidentiary report, and sanction. Institutions without an equivalent codified process should expect that, absent clear stage-gates, a misconduct case can default to years of litigation to resolve what a documented procedure might settle in months.

    The case remains open in part: Gino’s breach-of-contract and gender-discrimination claims against Harvard, and Harvard’s own defamation suit against Gino, were both still active as of late 2025. The eventual rulings will further shape how far US courts are willing to scrutinise a university’s internal misconduct-investigation process.

    For broader context on how institutions structure research-integrity roles and terminology, see CASRAI’s research administration resources and the CASRAI Dictionary.